BRC News

BRC supported researchers have found that a high dose of simvastatin significantly reduces brain shrinkage in secondary progressive multiple sclerosis.

An exhibition of photographs featuring UCL and UCLH researchers is moving to Brighton this month to shine a light on the world of clinical research.

A researcher from NIHR Queen’s Square Dementia Biomedical Research Unit is to investigate biological changes that occur in nerve cells prior to their demise as a way to help develop treatments for dementia.

Just a few places remain on the PPI workshops that will run throughout March.

An applied health research collaboration with funds of £44 million has been launched to improve health outcomes for people living in London, Hertfordshire, Bedfordshire and Essex.

A new MSc in Computational and Genomic Medicine is starting in September at UCL.

Staff from across UCLH have been honoured at this year’s Celebrating Excellence Awards, which included a ‘Contribution to World Class Research’ category.

A group of UCL researchers is beginning a £500,000 clinical trial to examine the effects of a novel drug that modulates communication between nerve cells in the brain. 

Throughout March a range of patient, carer and public engagement and development opportunities will be provided across the clinical and academic workforce in the UCLPartners’ Academic Health Science Centre partnership. 

The BRC, with funding from the Wellcome Trust, has awarded £12,000 in new Patient and Public Involvement (PPI) bursaries. 

UCLH researchers have been awarded a National Institute of Health Research (NIHR) grant of £2 million to research ways of reducing the rate of post-traumatic stress disorder in intensive care patients.

Nearly 80% of ‘A’ level students from underprivileged backgrounds attending the BRC summer school go on to university, a third of which are prestigious ‘Russell Group’ universities, according to a report out this month.

The BRC Cardiometabolic Programme has awarded its first career development fellowships to Dr Gabrielle Captur and Dr Stefano Masi.

An international team of researchers have shown for the first time that switching off the mutant protein that causes the fatal brain disorder Huntington’s disease (HD) can reverse abnormalities in living cells taken from patients with the disease. Image courtesy of C. Guérin, Wellcome Images 

Recruitment has begun to a major new study to see if there is a better way to identify younger people with early hypertension by looking at whether the way in which their blood pressure is measured can be refined.   Image: new device to be used in the study